サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：解熱鎮痛剤の世界市場2023-2030
市場調査レポート
商品コード
1311877

解熱鎮痛剤の世界市場2023-2030

Global Antipyretic Drug Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 147 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
解熱鎮痛剤の世界市場2023-2030
出版日: 2023年06月28日
発行: Orion Market Research
ページ情報: 英文 147 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

解熱鎮痛剤の世界市場は、予測期間中（2023～2030年）にCAGR 2.2％で成長すると予測されています。解熱剤は、通常は何らかの炎症源によって誘発される発熱を軽減または除去する医薬品です。解熱剤は、視床下部にプロスタグランジンによる体温上昇を上書きさせる。インフルエンザの影響はさまざまで、米国では毎年、人々の健康にかなりの負担をかけています。米国疾病管理予防センター（CDC）は、4,100万人の罹患者のうち、インフルエンザと診断されたのは約900万人であると推定しています。このうち、2010年から2020年の間に、毎年約14万～71万人が病院へ入院し、1万2000～52万人が死亡することが報告されています。

そのため、世界中でこのようなインフルエンザを治療する医薬品の需要と開発がかなり高まっています。例えば、Johnson & Johnson Koreaは2022年5月、韓国初の粉末タイプの小児用解熱鎮痛剤「チルドレン・タイレノール粉末160mg」を発売しました。頭痛、神経痛、筋肉痛、捻挫痛、生理痛、歯痛、関節痛などのほか、風邪による発熱や痛みなど、さまざまな症状を緩和する「こどもタイレノール粉末」は、発熱や陣痛などにも幅広く使用できます。そのため、市場関係者は新しいタイプの解熱鎮痛剤の導入にも力を入れており、市場の成長をさらに後押しするものと思われます。

セグメント別展望

市販薬（OTC）サブセグメントが解熱鎮痛剤の世界市場でかなりのシェアを占めると予測される

業界別では、市販薬（OTC）が世界の解熱鎮痛剤市場でかなりのシェアを占めると予想されます。このセグメントの成長は、医師の処方箋なしに解熱鎮痛剤を簡単に入手できることに起因しています。そのため、製薬業界の主要企業は、組織のための効果的な解熱鎮痛剤ソリューションへの投資に注力しています。例えば、2021年8月、英国政府はパラセタモールとイブプロフェンの配合薬を一般販売することを承認しました。この薬は、1錠あたり200mgのイブプロフェンと500mgのパラセタモールを含みます。この薬は、処方箋なしで一般に販売される予定です。

地域別展望

アジア太平洋地域は世界の解熱鎮痛剤市場において著しいCAGRで成長すると予想される

すべての地域の中で、アジア太平洋地域は予測期間中にかなりのCAGRで成長すると予想されています。同地域の成長の背景には、慢性疾患やウイルス性疾患を抱える高齢者人口の増加があります。世界的に腸チフス患者の半数以上がインドで発生していると予測されているが、現代の疾病負担に関するデータが不足しているため、公的なワクチン接種の実施率は低いままです。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Sun pharmaceuticals Industries Ltd.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Johnson and Johnson（J&J）
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Pfizer Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 解熱鎮痛剤の世界市場：タイプ別
    • パラセタモール
    • イブプロフェン
    • 非ステロイド性抗炎症薬（NSAID）
    • その他
  • 解熱鎮痛剤の世界市場：販売タイプ別
    • 処方薬（Rx）
    • 市販薬（OTC）
  • 解熱鎮痛剤の世界市場：販売チャネル別
    • 病院薬局
    • ドラッグストアおよび小売薬局
    • オンライン薬局
    • その他（スーパーマーケット）

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • BASF SE
  • CIPLA Ltd
  • Cumberland Pharmaceuticals
  • Divi's Laboratories Limited
  • Dr. Reddy's Laboratories
  • Elfin Drugs Private Limited
  • Glenmark Pharmaceuticals
  • GSK Pharmaceuticals
  • Jordanian Pharmaceutical Manufacturing
  • LUPIN Limited
  • Novartis AG
  • NPS MedicineWise
  • Strides Pharma
  • Torrent Pharmaceuticals Ltd
  • ZYDUS Life
図表

LIST OF TABLES

  • 1. GLOBAL ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL PARACETAMOL MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL IBUPROFEN MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL NSAID MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL OTHER TYPES OF ANTIPYRETIC DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL ANTIPYRETIC MARKET RESEARCH AND ANALYSIS BY SALES TYPE, 2022-2030 ($ MILLION)
  • 7. GLOBAL ANTIPYRETIC DRUG BY PRESCRIPTION MARKET RESEARCH AND ANALYSIS REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL ANTIPYRETIC DRUG BY OVER-THE-COUNTER MARKET RESEARCH AND ANALYSIS REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL ANTIPYRETIC MARKET RESEARCH AND ANALYSIS BY SALES CHANNEL, 2022-2030 ($ MILLION)
  • 10. GLOBAL ANTIPYRETIC DRUG IN HOSPITAL PHARMACIES MARKET RESEARCH AND ANALYSIS REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL ANTIPYRETIC DRUG IN DRUG STORE AND RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL ANTIPYRETIC DRUG IN ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL ANTIPYRETIC DRUG IN OTHER SALES CHANNELS MARKET RESEARCH AND ANALYSIS REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALES TYPE, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALES CHANNELS, 2022-2030 ($ MILLION)
  • 19. EUROPEAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALES TYPE, 2022-2030 ($ MILLION)
  • 22. EUROPEAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALES CHANNELS, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALES TYPE, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALES CHANNELS, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALES TYPE, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALE CHANNELS, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ANTIPYRETIC DRUG MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL PARACETAMOL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL IBUPROFEN MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL NSAID MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL OTHER TYPES OF ANTIPYRETIC DRUG MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL ANTIPYRETIC DRUG MARKET SHARE ANALYSIS BY SALES TYPE, 2022-2030 ($ MILLION)
  • 7. GLOBAL ANTIPYRETIC DRUG BY PRESCRIPTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL ANTIPYRETIC DRUG BY OVER-THE-COUNTER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL ANTIPYRETIC DRUG MARKET SHARE ANALYSIS BY SALES CHANNELS, 2022-2030 ($ MILLION)
  • 10. GLOBAL ANTIPYRETIC DRUG IN HOSPITAL PHARMACIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL ANTIPYRETIC DRUG IN DRUG STORE AND RETAIL PHARMACIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL ANTIPYRETIC DRUG IN ONLINE PHARMACIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL ANTIPYRETIC DRUG IN OTHER SALES CHANNELS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL ANTIPYRETIC DRUG MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027476

Title: Global Antipyretic Drug Market Size, Share & Trends Analysis Report by Type (Paracetamol, Ibuprofen, Aspirin, NSAID and Others), by Sales Type (Prescription and Over the Counter (OTC)), by Sales Channels (Hospital Pharmacies, Drug Store & Retail Pharmacies, Online Pharmacies, and Others) Forecast Period (2023-2030).

The global antipyretic drug market is anticipated to grow at a CAGR of 2.2% during the forecast period (2023-2030). An antipyretic is a pharmaceutical agent that reduces or eliminates a fever, usually induced by some source of inflammation. Antipyretics cause the hypothalamus to override a prostaglandin-induced increase in temperature. The effects of flu varies it places a substantial burden on the health of people in the US each year. Center for Disease Control and Prevention (CDC) have estimated that out of 41 million incidences of illness, flu was diagnosed to be around 9 million. Among these, approximately 140,000-710,000 hospitalizations, and 12,000-52,000 mortalities have been experiences annually between 2010 and 2020.

Thus, there is a considerable increase in the demand and development of drugs treating such flu across the globe. For instance in May 2022, Johnson & Johnson Korea released the first powder-type children's antipyretic painkiller Children's Tylenol powder 160 mg in Korea. Children's Tylenol powder which gives relief from various effects such as headache, neuralgia, muscle pain, sprain pain, menstrual pain, toothache, and joint pain, as well as fever and pain caused by a cold, so it can be widely used for fever and labor. Hence, the market players are also focusing on introducing new dosage types of Antipyretic Drug solutions which will further bolster the market growth.

Segmental Outlook

The global antipyretic drug market is segmented on type, sales type, and sales channels. Based on the type, the market is sub-segmented into Paracetamol, Ibuprofen, Aspirin, NSAID, and others. Based on the sales type, the market is sub-segmented into prescription and OTC. Further, on the basis of dosage form, the market is sub-segmented into Tablet, Syrup, Injection, and Paste. Based on sales channels, the market is sub-segmented into hospital pharmacies, drug store & retail pharmacies, online pharmacies, and others.

The Over the Counter (OTC) Sub-Segment Is Anticipated To Hold a Considerable Share of the Global Antipyretic Drug Market

Among the industry vertical, the Over the Counter (OTC) is expected to hold a considerable share of the global antipyretic drug market. The segmental growth is attributed to the easy availability of antipyretic drug without doctor's prescription. Owing to which major businesses of the pharmaceutical industry are focusing on investing in effective antipyretic drug solutions for their organizations. For instance, in August 2021, UK government approved combined paracetamol and ibuprofen medicine for general sale a medicine that contains 200mg of ibuprofen and 500mg of paracetamol per tablet. It will become available without any medical prescription for public.

Regional Outlook

The global Antipyretic Drug market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe, due to maximum number of COVID-19 cases and deaths, thus, with a plethora of patients reporting fever as a common symptom- the sales of antipyretics rocketed in the year, and others.

The Asia-Pacific Region is expected to grow at a Significant CAGR in the Global Antipyretic Drug Market

Among all regions, the Asia-Pacific regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the growing geriatric population with other forms of chronic and viral illnesses. More than half of the cases of typhoid fever globally were projected to have occurred in India, the implementation of public vaccination has remained low, due to the lack of data regarding the contemporary disease burden.

Market Players Outlook

The major companies serving the Antipyretic Drug market include: Sun Pharmaceuticals Industries Ltd., Pfizer Inc., Johnson and Johnson (J&J), Glenmark Pharmaceuticals, Cipla Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2023, the Food and Drug Administration (FDA) expanded the approval of Caldolor (ibuprofen injection) to include infants 3 to 6 months of age for the treatment of pain and fever. Previously, the treatment was approved for patients 6 months of age and older.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global antipyretic drug market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Sun pharmaceuticals Industries Ltd.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Johnson and Johnson (J&J)
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Pfizer Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Antipyretic Drug Market By Type
    • 4.1.1. Paracetamol
    • 4.1.2. Ibuprofen
    • 4.1.3. Non-Steroidal Anti-Inflammatory Drugs (NSAID)
    • 4.1.4. Others
  • 4.2. Global Antipyretic Drug Market by Sales Type
    • 4.2.1. Prescription (Rx)
    • 4.2.2. Over the Counter (OTC)
  • 4.3. Global Antipyretic Drug Market by Sales Channel
    • 4.3.1. Hospital Pharmacies
    • 4.3.2. Drug Store & Retail Pharmacies
    • 4.3.3. Online Pharmacies
    • 4.3.4. Others (Supermarkets)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. BASF SE
  • 6.2. CIPLA Ltd
  • 6.3. Cumberland Pharmaceuticals
  • 6.4. Divi's Laboratories Limited
  • 6.5. Dr. Reddy's Laboratories
  • 6.6. Elfin Drugs Private Limited
  • 6.7. Glenmark Pharmaceuticals
  • 6.8. GSK Pharmaceuticals
  • 6.9. Jordanian Pharmaceutical Manufacturing
  • 6.10. LUPIN Limited
  • 6.11. Novartis AG
  • 6.12. NPS MedicineWise
  • 6.13. Strides Pharma
  • 6.14. Torrent Pharmaceuticals Ltd
  • 6.15. ZYDUS Life